Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

GAVIN SCHWARZ

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1093848988
CMS profile
276769
Location
WEST HARTFORD, CT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$24,179.30

36 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Page 1 of 1; records 1–36 of 36 matching records. This page contains 36 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

GAVIN SCHWARZ

NPI 1093848988 · CMS profile ID 276769

Allopathic & Osteopathic Physicians / Allergy & Immunology

WEST HARTFORD, CT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–36 of 36 matching records. This page contains 36 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1093848988?year=2020&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
GAVIN SCHWARZ, NPI 1093848988, CMS profile ID 276769. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–36 of 36 matching records. This page contains 36 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1093848988?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). GAVIN SCHWARZ, NPI 1093848988, CMS profile ID 276769. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–36 of 36 matching records. This page contains 36 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1093848988?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
GAVIN SCHWARZ, NPI 1093848988, CMS profile ID 276769, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–36 of 36 matching records. This page contains 36 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1093848988?year=2020&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

36 matching records · $24,179.30 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 36 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–36 of 36.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $1,350.0012/20/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738690275 CMS
Novartis Pharmaceuticals Corporation $17.1412/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726122135 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,125.0012/14/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747296503 CMS
Grifols USA, LLC $1,200.0011/30/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750418673 CMS
AstraZeneca Pharmaceuticals LP $1,350.0011/09/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738688219 CMS
AstraZeneca Pharmaceuticals LP $125.0010/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738693661 CMS
Grifols USA, LLC $1,200.0010/27/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750401413 CMS
GENZYME CORPORATION $121.8410/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744210093 CMS
GENZYME CORPORATION $2,363.0010/21/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744210095 CMS
AstraZeneca Pharmaceuticals LP $14.9010/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738707431 CMS
AstraZeneca Pharmaceuticals LP $11.5610/08/2020 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738697095 CMS
GENZYME CORPORATION $119.2809/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744210089 CMS
GENZYME CORPORATION $2,700.0009/30/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744210091 CMS
PFIZER INC. $1,525.0009/04/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743285623 CMS
AstraZeneca Pharmaceuticals LP $650.0008/31/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738685751 CMS
CSL Behring $24.5608/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728953097 CMS
AstraZeneca Pharmaceuticals LP $750.0007/27/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738695853 CMS
PFIZER INC. $555.0005/25/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743228741 CMS
Grifols USA, LLC $2,000.0004/30/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750401605 CMS
Regeneron Healthcare Solutions, Inc. $61.6804/09/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 724453191 CMS
Regeneron Healthcare Solutions, Inc. $18.7904/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 724453193 CMS
Regeneron Healthcare Solutions, Inc. $8.6704/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 724453197 CMS
Regeneron Healthcare Solutions, Inc. $28.0004/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 724453199 CMS
Regeneron Healthcare Solutions, Inc. $3,150.0003/24/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 724453187 CMS
Regeneron Healthcare Solutions, Inc. $144.1103/07/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 724453185 CMS
Regeneron Healthcare Solutions, Inc. $30.2703/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726906313 CMS
Regeneron Healthcare Solutions, Inc. $9.9803/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726906315 CMS
Regeneron Healthcare Solutions, Inc. $67.5003/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726906317 CMS
Regeneron Healthcare Solutions, Inc. $10.5603/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726906319 CMS
Regeneron Healthcare Solutions, Inc. $52.2003/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726906321 CMS
GENZYME CORPORATION $121.3603/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744210039 CMS
GENZYME CORPORATION $2,700.0003/05/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744210041 CMS
Regeneron Healthcare Solutions, Inc. $98.5403/04/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 724453181 CMS
Regeneron Healthcare Solutions, Inc. $370.8201/23/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 724453175 CMS
Regeneron Healthcare Solutions, Inc. $35.2501/23/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 724453179 CMS
Grifols USA, LLC $69.2901/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750403479 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $34,199.92 53
PY2020 $24,179.30 36
PY2021 $34,067.90 31
PY2022 $26,168.45 33
PY2023 $42,176.35 55
PY2024 $47,210.74 64
PY2025 $54,417.04 57

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2021 Principal investigator $7,064.60 5
PY2020 Principal investigator $32,342.25 30

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

30 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $23.40 07/16/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061409
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $3,500.00 07/06/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061405
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $38.84 07/06/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061407
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,388.70 06/10/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061401
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $41.00 05/13/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061355
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $41.00 05/13/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061357
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $26.00 05/13/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061359
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $381.80 05/13/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061361
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,936.00 05/13/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061363
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,917.00 05/13/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061365
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,917.00 05/13/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061367
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,566.00 05/13/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061369
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,566.00 05/13/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061371
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,543.00 05/13/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061373
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,543.00 05/13/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061375
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $2,332.00 05/13/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061377
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $41.00 05/13/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061379
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $41.00 05/13/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061381
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $41.00 05/13/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061383
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $41.00 05/13/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061385
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $41.00 05/13/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061387
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $41.00 05/13/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061389
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $41.00 05/13/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061391
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $41.00 05/13/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061393
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $41.00 05/13/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061395
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $41.00 05/13/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061397
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $2,332.00 05/13/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061399
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $9,000.00 04/22/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061347
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $639.51 04/22/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061349
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $200.00 04/22/2020 Covered Recipient Teaching Hospital
CONNECTICUT CHILDRENS MEDICAL CENTER
EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY AND PHARMACOKINETIC EVALUATION OF HYQVIA IN PEDIATRIC PIDD SUBJECTS No dispute reported 06/30/2026 737061351